News Chart Akeso, Inc.

Equities

9926

KYG0146B1032

Biotechnology & Medical Research

Market Closed - Hong Kong S.E. Other stock markets 01:39:05 15/05/2026 pm IST			5-day change	1st Jan Change
120.20 ^HKD	-2.91%		-10.30%	+6.37%

15/05	Akeso Inc Announces Phase II Data of Ligufalimab Combination Therapy in Frontline Acute Myeloid Leukemia	CI
28/04	Biodlink International Company Limited Announces Board and Board Committee Changes, Effective from 29 April 2026	CI

aca993a09868361788dab3e68817.m5skjWpOALZN9a-yaiQNbHQBi_XN_JP1PqApnqDZZPU.9dVt7y02Nvc8rduKDhBSFQVn-ZS6kt2kaNF4-cmoU636-Gb3JD9q93y04g~2a5e790920420cc718edb33ca928a62a